Evidence map›Paper›PMID 34623903›Full record

ArticleScience immunology2021

Cholesterol 25-hydroxylase is a metabolic switch to constrain T cell-mediated inflammation in the skin.

H Takahashi, H Nomura, H Iriki, A Kubo, K Isami, Y Mikami, M Mukai, T Sasaki, J Yamagami, J Kudoh and 10 more

Abstract read
In one paragraph

Article in Science immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Targeting SQLE-mediated cholesterol metabolism to enhance CD8Journal for immunotherapy of cancer · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. Tubulin Acetylation: A Critical Regulator of Microtubule Function.Results and problems in cell differentiation · 2025
    Review
  9. Review
  10. Review
  11. Review
  12. Involvement ofFrontiers in immunology · 2023
    Article
  13. Sterols and immune mechanisms in asthma.The Journal of allergy and clinical immunology · 2023
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

H TakahashiDepartment of Dermatology, Keio University School of Medicine, Tokyo 160-8582, Japan.ORCID 0000-0001-6768-8821
H NomuraDepartment of Dermatology, Keio University School of Medicine, Tokyo 160-8582, Japan.
H IrikiDepartment of Dermatology, Keio University School of Medicine, Tokyo 160-8582, Japan.ORCID 0000-0003-4022-8950
A KuboDepartment of Biochemistry, Keio University School of Medicine, Tokyo 160-8582, Japan.ORCID 0000-0002-6003-227X
K IsamiDepartment of Dermatology, Keio University School of Medicine, Tokyo 160-8582, Japan.ORCID 0000-0002-9958-2164
Y MikamiMolecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0001-5104-4415
M MukaiDepartment of Dermatology, Keio University School of Medicine, Tokyo 160-8582, Japan.ORCID 0000-0003-1173-0538
T SasakiCenter for Supercentenarian Medical Research, Keio University School of Medicine, Tokyo 160-8582, Japan.ORCID 0000-0002-6275-046X
J YamagamiDepartment of Dermatology, Keio University School of Medicine, Tokyo 160-8582, Japan.
J KudohLaboratory of Gene Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan.
H ItoDepartment of Dermatology, Keio University School of Medicine, Tokyo 160-8582, Japan.
A KamataDepartment of Dermatology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Y KurebayashiDepartment of Pathology, Keio University School of Medicine, Tokyo 160-8582, Japan.ORCID 0000-0003-3773-0851
H YoshidaDivision of Molecular and Cellular Immunoscience, Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Saga 849-8501, Japan.ORCID 0000-0003-3447-117X
A YoshimuraDepartment of Immunology and Microbiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
H W SunBiodata Mining and Discovery Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0001-9765-6505
M SuematsuDepartment of Biochemistry, Keio University School of Medicine, Tokyo 160-8582, Japan.ORCID 0000-0002-7165-6336
J J O'SheaMolecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0002-6456-9752
Y KannoMolecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
M AmagaiDepartment of Dermatology, Keio University School of Medicine, Tokyo 160-8582, Japan.

Funding

Stat transcription factors in immunoregulation and autoimmune diseaseZIAAR041159 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI O'SHEA, JOHN · 2009 to 2025
$49.3M
Stat transcription factors in immunoregulation and autoimmune diseaseZ01AR041159 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI O'SHEA, JOHN · 2008 to 2008
$1.8M
Intramural NIH HHS Z01 AR041159Intramural NIH HHS ZIA AR041159
6 · The paper itself

Abstract

Interleukin-27 (IL-27) is an immunoregulatory cytokine whose essential function is to limit immune responses. We found that the gene encoding cholesterol 25-hydroxylase (Ch25h) was induced in CD4

Indexed as

AnimalsCD4-Positive T-LymphocytesCholesterolInflammationInflammation MediatorsInterleukin-27MiceMice, Inbred C57BLMice, KnockoutSkinSteroid HydroxylasesCholesterolcholesterol 25-hydroxylaseInflammation MediatorsInterleukin-27Steroid Hydroxylases

Identifiers

PMID34623903
PMCPMC9780739

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.